ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0546

The Great Masquerade: Beyond Textbook Seronegative Immune Complex Glomerulopathy

Session Information

Category: Glomerular Diseases

  • 1402 Glomerular Diseases: Clinical, Outcomes, and Therapeutics

Authors

  • Naing, Kyaw Moe, VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
  • Oldford, Elaine J., VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
  • Gardezi, Lemar Ahmad, VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
  • Rayas, Jose Luis, VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
  • Kent, Devon Gerard, VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
  • Al-adroos, Hira H., VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
  • Sumida, Keiichi, VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
  • Sharma, Shilpa, VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
  • Rhee, Connie, VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
  • Siu, Man Kit Michael, VA Greater Los Angeles Healthcare System, Los Angeles, California, United States
Introduction

Proteinuria in elderly diabetics is often attributed to diabetic nephropathy (DN). However, abrupt nephrotic syndrome and absence of retinopathy should raise suspicion for non-diabetic kidney disease (NDKD). We report an atypical seronegative immune complex glomerulopathy with fibrillary features responsive to immunosuppression despite incomplete diagnostic classification.

Case Description

A 78-year-old man with longstanding, well-controlled T2DM without retinopathy presented with one month of anasarca after a recent uppre respiratory infection. Evaluation showed albumin 1.7 g/dL and proteinuria 26.5 g/day. Serologies (anti-PLA2R, ANA, ANCA, viral, paraproteinemia) and complements were normal.

Kidney biopsy demonstrated nodular diabetic glomerulosclerosis with immune complex injury. IF showed granular IgG/C3 staining. EM demonstrated subepithelial deposits and mesangial fibrils (12.4–16.4 nm). DNAJB9 staining was negative, arguing against classic fibrillary glomerulonephritis. Congo red staining was positive for ALECT2 amyloid. Findings were unclassifiable.

Despite 40–50% IFTA, nephrotic syndrome prompted treatment with RAAS blockade, rituximab (1 g ×2), and corticosteroid taper. Proteinuria improved 71.7% (26.5 g/day to 7.5 g/day) with stable renal function.

Discussion

This case highlights the complexity of overlapping diabetic and unclassified immune complex pathology. Response to B-cell depletion supported a treatable immune-mediated driver beyond diabetic nephropathy. In cases with clinical red flags, empiric therapy may be justified despite diagnostic uncertainty.

Figure 1:
(A) Light microscopy: Nodular mesangial expansion consistent with diabetic glomerulosclerosis.
(B) Immunofluorescence: Granular capillary loop IgG staining supporting immune complex injury.
(C) Electron microscopy: Mesangial fibrils measuring 12.4–16.4 nm with associated subepithelial deposits.
(D) Congo red-positive ALECT2 amyloid deposition.